안구건조증 : 시장 인사이트, 역학 및 시장 예측(-2034년)

DelveInsight's "Dry Eye Disease - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Dry Eye Disease, historical and forecasted epidemiology as well as the Dry Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Dry Eye Disease market report provides current treatment practices, emerging drugs, Dry Eye Disease market share of the individual therapies, current and forecasted Dry Eye Disease market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Dry Eye Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2020-2034

Dry Eye Disease Disease Understanding and Treatment Algorithm

The DelveInsight Dry Eye Disease market report gives a thorough understanding of the Dry Eye Disease by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Dry Eye Disease.

Treatment

It covers the details of conventional and current medical therapies available in the Dry Eye Disease market for the treatment of the condition. It also provides Dry Eye Disease treatment algorithms and guidelines in the United States, Europe, and Japan.

Dry Eye Disease Epidemiology

The Dry Eye Disease epidemiology division provide insights about historical and current Dry Eye Disease patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Dry Eye Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Dry Eye Disease Epidemiology

The epidemiology segment also provides the Dry Eye Disease epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Dry Eye Disease Drug Chapters

Drug chapter segment of the Dry Eye Disease report encloses the detailed analysis of Dry Eye Disease marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Dry Eye Disease clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Dry Eye Disease treatment.

Dry Eye Disease Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Dry Eye Disease treatment.

Dry Eye Disease Market Outlook

The Dry Eye Disease market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Dry Eye Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Dry Eye Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Dry Eye Disease market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Dry Eye Disease market in 7MM.

The United States Market Outlook

This section provides the total Dry Eye Disease market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Dry Eye Disease market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Dry Eye Disease market size and market size by therapies in Japan is also mentioned.

Dry Eye Disease Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Dry Eye Disease market or expected to get launched in the market during the study period 2020-2034. The analysis covers Dry Eye Disease market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Dry Eye Disease Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Dry Eye Disease key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Dry Eye Disease emerging therapies.

Reimbursement Scenario in Dry Eye Disease

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Dry Eye Disease domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Dry Eye Disease market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Dry Eye Disease Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

• The report covers the descriptive overview of Dry Eye Disease, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Dry Eye Disease epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Dry Eye Disease are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Dry Eye Disease market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Dry Eye Disease market

Report Highlights:

• In the coming years, Dry Eye Disease market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Dry Eye Disease R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Dry Eye Disease. Launch of emerging therapies will significantly impact the Dry Eye Disease market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Dry Eye Disease
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Dry Eye Disease Report Insights

• Patient Population
• Therapeutic Approaches
• Dry Eye Disease Pipeline Analysis
• Dry Eye Disease Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Dry Eye Disease Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Dry Eye Disease Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Dry Eye Disease Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions:

Market Insights:

• What was the Dry Eye Disease market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Dry Eye Disease total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Dry Eye Disease market size during the forecast period (2024-2034)?
• At what CAGR, the Dry Eye Disease market is expected to grow in 7MM during the forecast period (2020-2034)?
• What would be the Dry Eye Disease market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Dry Eye Disease market growth till 2032, and what will be the resultant market Size in the year 2034?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What is the disease risk, burden and unmet needs of the Dry Eye Disease?
• What is the historical Dry Eye Disease patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Dry Eye Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Dry Eye Disease?
• Out of all 7MM countries, which country would have the highest prevalent population of Dry Eye Disease during the forecast period (2020-2034)?
• At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Dry Eye Disease treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of Dry Eye Disease in the USA, Europe, and Japan?
• What are the Dry Eye Disease marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Dry Eye Disease?
• How many therapies are developed by each company for Dry Eye Disease treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Dry Eye Disease treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Dry Eye Disease therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Dry Eye Disease and their status?
• What are the key designations that have been granted for the emerging therapies for Dry Eye Disease?
• What are the global historical and forecasted market of Dry Eye Disease?

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Dry Eye Disease market
• To understand the future market competition in the Dry Eye Disease market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Dry Eye Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Dry Eye Disease market
• To understand the future market competition in the Dry Eye Disease market

Table of Contents

1. Key Insights

2. Executive Summary of Dry Eye Disease

3. Competitive Intelligence Analysis for Dry Eye Disease

4. Dry Eye Disease: Market Overview at a Glance

• 4.1. Dry Eye Disease Total Market Share (%) Distribution in 2020
• 4.2. Dry Eye Disease Total Market Share (%) Distribution in 2034

5. Dry Eye Disease: Disease Background and Overview

• 5.1. Introduction
• 5.2. Sign and Symptoms
• 5.3. Pathophysiology
• 5.4. Risk Factors
• 5.5. Diagnosis

6. Patient Journey

7. Dry Eye Disease Epidemiology and Patient Population

• 7.1. Epidemiology Key Findings
• 7.2. Assumptions and Rationale: 7MM
• 7.3. Epidemiology Scenario: 7MM
  • 7.3.1. Dry Eye Disease Epidemiology Scenario in the 7MM (2020-2034)
• 7.4. United States Epidemiology
  • 7.4.1. Dry Eye Disease Epidemiology Scenario in the United States (2020-2034)
• 7.5. EU-5 Country-wise Epidemiology
  • 7.5.1. Germany Epidemiology
    • 7.5.1.1. Dry Eye Disease Epidemiology Scenario in Germany (2020-2034)
  • 7.5.2. France Epidemiology
    • 7.5.2.1. Dry Eye Disease Epidemiology Scenario in France (2020-2034)
  • 7.5.3. Italy Epidemiology
    • 7.5.3.1. Dry Eye Disease Epidemiology Scenario in Italy (2020-2034)
  • 7.5.4. Spain Epidemiology
    • 7.5.4.1. Dry Eye Disease Epidemiology Scenario in Spain (2020-2034)
  • 7.5.5. United Kingdom Epidemiology
    • 7.5.5.1. Dry Eye Disease Epidemiology Scenario in the United Kingdom (2020-2034)
  • 7.5.6. Japan Epidemiology
    • 7.5.6.1. Dry Eye Disease Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

• 8.1. Dry Eye Disease Treatment and Management
• 8.2. Dry Eye Disease Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Dry Eye Disease Treatment

11. Marketed Products

• 11.1. List of Marketed Products in the 7MM
• 11.2. Drug Name: Company Name
  • 11.2.1. Product Description
  • 11.2.2. Regulatory Milestones
  • 11.2.3. Other Developmental Activities
  • 11.2.4. Pivotal Clinical Trials
  • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

• 12.1. Key Cross
• 12.2. Drug Name: Company Name
  • 12.2.1. Product Description
  • 12.2.2. Other Developmental Activities
  • 12.2.3. Clinical Development
  • 12.2.4. Safety and Efficacy
  • 12.2.5. Product Profile

List to be continued in report

13. Dry Eye Disease: Seven Major Market Analysis

• 13.1. Key Findings
• 13.2. Dry Eye Disease Market Size in 7MM
• 13.3. Dry Eye Disease Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

• 15.1. United States: Market Size
  • 15.1.1. Dry Eye Disease Total Market Size in the United States
  • 15.1.2. Dry Eye Disease Market Size by Therapies in the United States
• 15.2. EU-5 countries: Market Size and Outlook
• 15.3. Germany Market Size
  • 15.3.1. Dry Eye Disease Total Market Size in Germany
  • 15.3.2. Dry Eye Disease Market Size by Therapies in Germany
• 15.4. France Market Size
  • 15.4.1. Dry Eye Disease Total Market Size in France
  • 15.4.2. Dry Eye Disease Market Size by Therapies in France
• 15.5. Italy Market Size
  • 15.5.1. Dry Eye Disease Total Market Size in Italy
  • 15.5.2. Dry Eye Disease Market Size by Therapies in Italy
• 15.6. Spain Market Size
  • 15.6.1. Dry Eye Disease Total Market Size in Spain
  • 15.6.2. Dry Eye Disease Market Size by Therapies in Spain
• 15.7. United Kingdom Market Size
  • 15.7.1. Dry Eye Disease Total Market Size in the United Kingdom
  • 15.7.2. Dry Eye Disease Market Size by Therapies in the United Kingdom
• 15.8. Japan Market Outlook
  • 15.8.1. Japan Market Size
  • 15.8.2. Dry Eye Disease Total Market Size in Japan
  • 15.8.3. Dry Eye Disease Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Dry Eye Disease

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

• 20.1. Bibliography
• 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.